Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 220,86
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Condizione: New. Satisfaction Guaranteed or your money back.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 226,68
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 217,14
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Like New. Like New. book.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 250,58
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 301,93
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Revaluation Books, Exeter, Regno Unito
EUR 351,19
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 350 pages. 9.25x6.25x0.75 inches. In Stock.
Da: moluna, Greven, Germania
EUR 271,04
Quantità: Più di 20 disponibili
Aggiungi al carrelloGebunden. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. ERIC R. BATES is Professor of Internal Medicine at the University of Michigan. Dr. Bates received his M.D. from the University of Michigan Medical School, Ann Arbor, and trained in internal medicine and cardiology at the University of Michigan Hospitals.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 355,21
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Reperfusion Therapy for Acute Myocardial Infarction provides a comprehensive review of reperfusion therapy for ST-segment elevation myocardial infarction (STEMI). Professor Eric R. Bates and his international team of contributors examine current and future reperfusion therapies for STEMI, in conjunction with the latest clinical trials and guidelines, to bring the most in-depth and thorough review of management strategies for these patients. This source addresses key developments that can reduce logistical barriers, improve times-to-treatment, and ensure that appropriate medications are administered in patient care.Demonstrating the benefits of reperfusion therapy, this volume:Examines fibrinolytic agents that can be used alone or in combination with other care regimens to improve the benefits of reperfusion therapy and reduce the risks of treatmentSummarizes the use of percutaneous coronary intervention (PCI) across the spectrum of reperfusion therapyHelps specialists identify barriers to the early treatment of patients in various practice environmentsReviews the clinical relevance and implications of recent clinical trials and the integration of these findings into the current practice of acute reperfusion therapy.